NPCE
NeuroPace Inc. (NPCE)
NASDAQ · Healthcare
NeuroPace Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- NeuroPace Inc. shareholder equity for the quarter ending December 31, 2025 were 19.0M, a 137.50% increase year-over-year.
- NeuroPace Inc. shareholder equity for 2025 were 19.0M, a 137.50% increase from 2024.
- NeuroPace Inc. shareholder equity for 2024 were 8.0M, a 61.20% decrease from 2023.
- NeuroPace Inc. shareholder equity for 2023 were 20.7M, a 40.61% decrease from 2022.
- NeuroPace Inc. shareholder equity for 2022 were 34.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| NeuroPace Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $19 |
| 2024 | $8 |
| 2023 | $21 |
| 2022 | $35 |
| 2021 | $74 |
| 2020 | $-148 |
| NeuroPace Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $19 |
| 2024-12-31 | $8 |
| 2023-12-31 | $21 |
| 2022-12-31 | $35 |
| 2021-12-31 | $74 |
| 2020-12-31 | $-148 |
NeuroPace Inc. Shareholder Equity — FAQ
NeuroPace Inc. (NPCE) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NPCE's shareholder equity history?
The chart and table above show NeuroPace Inc.'s shareholder equity by year and by quarter, including the growth rate.